000			02113 a2200625 4500
005			20250517042604.0
264		0	_c20160329
008			201603s 0 0 eng d
022			_a2374-2445
024	7		_a10.1001/jamaoncol.2015.43 _2doi
040			_aNLM _beng _cNLM
100	1		_aDinan, Michaela A
245	0	0	_aInitial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009. _h[electronic resource]
260			_bJAMA oncology _cMay 2015
300			_a158-66 p. _bdigital
500			_aPublication Type: Journal Article; Observational Study; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aBreast Neoplasms _xethnology
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aChi-Square Distribution
650	0	4	_aFemale
650	0	4	_aGene Expression Profiling _xmethods
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aGuideline Adherence
650	0	4	_aHealthcare Disparities
650	0	4	_aHumans
650	0	4	_aMedicare _xstatistics & numerical data
650	0	4	_aMultivariate Analysis
650	0	4	_aNeoplasm Recurrence, Local
650	0	4	_aNeoplasm Staging
650	0	4	_aOdds Ratio
650	0	4	_aPhenotype
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aPractice Patterns, Physicians' _xtrends
650	0	4	_aPredictive Value of Tests
650	0	4	_aRacial Groups
650	0	4	_aResidence Characteristics
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aSEER Program
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States _xepidemiology
700	1		_aMi, Xiaojuan
700	1		_aReed, Shelby D
700	1		_aHirsch, Bradford R
700	1		_aLyman, Gary H
700	1		_aCurtis, Lesley H
773	0		_tJAMA oncology _gvol. 1 _gno. 2 _gp. 158-66
856	4	0	_uhttps://doi.org/10.1001/jamaoncol.2015.43 _zAvailable from publisher's website
999			_c25080345 _d25080345